Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.78 USD | -3.63% | +17.73% | +83.14% |
05-07 | Citigroup Starts Summit Therapeutics With Buy Rating, $7 Price Target | MT |
05-01 | Transcript : Summit Therapeutics Inc., Q1 2024 Earnings Call, May 01, 2024 |
- Stock Market
- Equities
- SMMT Stock
- News Summit Therapeutics Inc.
- MarketScreener Editorial Features